Found: 6
Select item for more details and to access through your institution.
Double-Inverse-Opal Photonic Crystals: The Route to Photonic Bandgap SwitchingThis work was partially supported by the German Federal Ministry of Education and Research (FKZ: 13N8278). We are grateful to P. Göppert (NaWoTec GmbH), H. Winkler (Merck KGaA), and S. Hartmann for their assistance with the SEM images.
- Published in:
- Advanced Functional Materials, 2006, v. 16, n. 7, p. 885, doi. 10.1002/adfm.200600068
- By:
- Publication type:
- Article
Pharmacokinetics, Pharmacodynamics, and Tolerability of Aleglitazar in Patients With Type 2 Diabetes: Results From a Randomized, Placebo-Controlled Clinical Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2010, v. 88, n. 2, p. 197, doi. 10.1038/clpt.2009.259
- By:
- Publication type:
- Article
Large-Area Three-Dimensional Structuring by Electrochemical Etching and Lithography The authors thank Dr. Jörg Schilling and Dr. Stefan Schweizer for helpful discussions on mask design and the etching process and Dr. Volker Lehmann for supplying pre-patterned silicon wafers. Stefan Richter is acknowledged for assistance with the FTIR measurements as well as Mrs. Sklarek for assistance in chemical lab. This project was partially funded via the DFG project WE 2637/3.
- Published in:
- Advanced Materials, 2004, v. 16, n. 23/24, p. 2166, doi. 10.1002/adma.200400436
- By:
- Publication type:
- Article
Computation of optical properties of Si-based photonic crystals with varying pore diameters.
- Published in:
- Physica Status Solidi (B), 2003, v. 240, n. 1, p. 124, doi. 10.1002/pssb.200301864
- By:
- Publication type:
- Article
Population Pharmacokinetics of Obinutuzumab (GA101) in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma and Exposure-Response in CLL.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2014, v. 3, n. 10, p. 1, doi. 10.1038/psp.2014.42
- By:
- Publication type:
- Article
COMBINING CD19‐4‐1BBL (RO7227166) WITH GLOFITAMAB IS SAFE AND SHOWS EARLY EFFICACY IN PATIENTS SUFFERING FROM RELAPSED OR REFRACTORY B‐CELL NON‐HODGKIN LYMPHOMA.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 136, doi. 10.1002/hon.3163_91
- By:
- Publication type:
- Article